These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3806102)

  • 1. Inhibition of monoamine oxidase by N-methylisoquinolinium ion.
    Naoi M; Hirata Y; Nagatsu T
    J Neurochem; 1987 Mar; 48(3):709-12. PubMed ID: 3806102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M; Nagatsu T
    J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
    Naoi M; Nagatsu T
    Life Sci; 1987 Jan; 40(4):321-8. PubMed ID: 3100896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships.
    Thull U; Kneubühler S; Gaillard P; Carrupt PA; Testa B; Altomare C; Carotti A; Jenner P; McNaught KS
    Biochem Pharmacol; 1995 Sep; 50(6):869-77. PubMed ID: 7575650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
    Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
    J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by 7-chloro-4-nitrobenzofurazan.
    Fu RC; Liu XF; Chen SU
    J Neurochem; 1990 Sep; 55(3):813-8. PubMed ID: 2384754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes.
    Naoi M; Ishiki R; Nomura Y; Hasegawa S; Nagatsu T
    Neurosci Lett; 1987 Feb; 74(2):232-6. PubMed ID: 2952905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on monoamine oxidase. XVIII. Enzymic properties of placental monoamine oxidase.
    Egashira T
    Jpn J Pharmacol; 1976 Aug; 26(4):493-500. PubMed ID: 12389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibition by novel antidepressant tetrindole.
    Medvedev AE; Kirkel AA; Kamyshanskaya NS; Moskvitina TA; Axenova LN; Gorkin VZ; Andreeva NI; Golovina SM; Mashkovsky MD
    Biochem Pharmacol; 1994 Jan; 47(2):303-8. PubMed ID: 8304974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence for existence of type A MAO in mitochondria from human placenta (author's transl)].
    Kikuchi R; Kinemuchi H
    Nihon Yakurigaku Zasshi; 1978 Sep; 74(6):763-72. PubMed ID: 711033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by Zn(2+) of A-form monoamine oxidase in monkey brain mitochondria.
    Egashira T; Takayama F; Sakai K
    J Pharmacol Sci; 2003 Mar; 91(3):239-45. PubMed ID: 12686747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions.
    Naoi M; Maruyama W; Sasuga S; Deng Y; Dostert P; Ohta S; Takahashi T
    Neurochem Int; 1994 Nov; 25(5):475-81. PubMed ID: 7849576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.